Аболевание

Nussbaum R., Polymeropoulos M. Genetics of Parkinson"s disease // Hum. Mol. Genet. - 1997.-6.-P. 1687-1697.Ogawa N., Miyazaki L, Tanaka K. et al. Dopamine D2 receptor mediated antioxidant and neuroprotective effects of ropinrole // 13-th International Congress on Parkinson"s Disease.

— Vancouver, 1999.Polymeropoulos M. Autosomal-dominant Parkinson"s disease and a-synuclein // Ann. Neurol. -1998.-44. (Suppl.) - S.63-S.64.Polymeropoulos M., Lavedan C., Leroy E. et al. Mutation in the a-synuclein in Parkinson"s disease // Science. - 1997. - 276. - P. 2045-2048.Rinne U. K. A five year double blind study with cabergoline versus levodopa in the treatment of early Parkinson"s disese // Ibid.Sehneider J., Gearing M., Robbins R. et al. Apolipoprotein E genotype in diverse neurodegenerative disorders // Ann. Neurol. - 1995. - 38. - P. 131-135.Smith L.